Pepys MB - Search Results

1

Classical and alternative pathway complement activation are not required for reactive systemic AA amyloid deposition in mice.

Hutchinson WL, Herbert J, Botto M, Pepys MB. Hutchinson WL, et al. Among authors: pepys mb. Immunology. 2004 Jun;112(2):250-4. doi: 10.1111/j.1365-2567.2004.01881.x. Immunology. 2004. PMID: 15147568 Free PMC article.

2

Lack of seasonal variation in C-reactive protein.

Fröhlich M, Sund M, Thorand B, Hutchinson WL, Pepys MB, Koenig W. Fröhlich M, et al. Among authors: pepys mb. Clin Chem. 2002 Mar;48(3):575-7. Clin Chem. 2002. PMID: 11861455 No abstract available.

3

Refinement of the association of serum C-reactive protein concentration and coronary heart disease risk by correction for within-subject variation over time: the MONICA Augsburg studies, 1984 and 1987.

Koenig W, Sund M, Fröhlich M, Löwel H, Hutchinson WL, Pepys MB. Koenig W, et al. Among authors: pepys mb. Am J Epidemiol. 2003 Aug 15;158(4):357-64. doi: 10.1093/aje/kwg135. Am J Epidemiol. 2003. PMID: 12915501

4

Determination of C-reactive protein: comparison of three high-sensitivity immunoassays.

Khuseyinova N, Imhof A, Trischler G, Rothenbacher D, Hutchinson WL, Pepys MB, Koenig W. Khuseyinova N, et al. Among authors: pepys mb. Clin Chem. 2003 Oct;49(10):1691-5. doi: 10.1373/49.10.1691. Clin Chem. 2003. PMID: 14500603 No abstract available.

5

Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination?

Gillmore JD, Hutchinson WL, Herbert J, Bybee A, Mitchell DA, Hasserjian RP, Yamamura K, Suzuki M, Sabin CA, Pepys MB. Gillmore JD, et al. Among authors: pepys mb. Immunology. 2004 Jun;112(2):255-64. doi: 10.1111/j.1365-2567.2004.01860.x. Immunology. 2004. PMID: 15147569 Free PMC article.

6

Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice.

Hirschfield GM, Gallimore JR, Kahan MC, Hutchinson WL, Sabin CA, Benson GM, Dhillon AP, Tennent GA, Pepys MB. Hirschfield GM, et al. Among authors: pepys mb. Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8309-14. doi: 10.1073/pnas.0503202102. Epub 2005 May 26. Proc Natl Acad Sci U S A. 2005. PMID: 15919817 Free PMC article.

7

Amyloidosis.

Pepys MB. Pepys MB. Annu Rev Med. 2006;57:223-41. doi: 10.1146/annurev.med.57.121304.131243. Annu Rev Med. 2006. PMID: 16409147 Review.

8

Is leptin an important physiological regulator of CRP?

Hutchinson WL, Coll AP, Gallimore JR, Tennent GA, Pepys MB. Hutchinson WL, et al. Among authors: pepys mb. Nat Med. 2007 Jan;13(1):17-8; author reply 19-21. doi: 10.1038/nm0107-17. Nat Med. 2007. PMID: 17206123 No abstract available.

9

Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE-/- mice.

Tennent GA, Hutchinson WL, Kahan MC, Hirschfield GM, Gallimore JR, Lewin J, Sabin CA, Dhillon AP, Pepys MB. Tennent GA, et al. Among authors: pepys mb. Atherosclerosis. 2008 Jan;196(1):248-255. doi: 10.1016/j.atherosclerosis.2007.05.010. Epub 2007 Jun 22. Atherosclerosis. 2008. PMID: 17588586

10

A molecular correlate of clinicopathology in transthyretin amyloidosis.

Pepys MB. Pepys MB. J Pathol. 2009 Jan;217(1):1-3. doi: 10.1002/path.2467. J Pathol. 2009. PMID: 19061244 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

382 results

Search Page